TEVA Trading Analysis - 09/16/2026 12:00 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced a settlement with the U.S. Department of Justice regarding allegations of misbranding and off-label promotion of certain medications.
• TEVA reported strong quarterly earnings, beating analyst expectations and citing increased sales of its key medications.
• The company announced a partnership with a leading research institution to develop new treatments for a range of diseases.

These headlines suggest that TEVA is actively addressing regulatory concerns, delivering strong financial performance, and investing in research and development. This could contribute to a positive outlook for the stock.

Fundamental Analysis:

Based on the provided fundamentals data:

• Total Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margins: 64.41%
• Operating Margins: 11.36%
• Profit Margins: 5.03%

The fundamentals indicate:

• TEVA has a high P/E ratio of 65.42, suggesting potential overvaluation.
• The debt-to-equity ratio is high at 4.14, which could be a concern.
• ROE is 9.14%, indicating decent profitability.
• Margins are relatively healthy, with gross margins at 64.41% and operating margins at 11.36%.

Overall, while TEVA's fundamentals show some strengths, the high P/E and debt-to-equity ratios are concerns.

Current Market Position:

Current price: $39.40

Recent price action: The stock has shown an upward trend, with the current price near the high end of the recent range.

Intraday momentum: The minute bars indicate a slight uptick in the last few minutes, with the stock trading near $39.40.

Technical Analysis:

The technical indicators suggest:

• The stock is above its 5, 20, and 50-day SMAs, indicating a bullish trend.
• RSI is at 58.7, which is neutral but leaning towards overbought territory.
• MACD is bullish, indicating upward momentum.

Bollinger Bands: The stock is trading near the upper band, which could indicate overbought conditions.

30-day high/low: The stock is near the high end of its 30-day range, indicating recent strength.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume analysis:

• Call dollar volume: $3,187,844
• Put dollar volume: $9,212
• Call/Put ratio: 99.7%/0.3%

The sentiment analysis indicates strong bullish conviction, with a significant dominance of call buying over put buying.

Key Price Levels:

25-Day Price Forecast:

TEVA is projected for $41.50 to $44.20

Based on current trends, momentum, and indicators, the stock is expected to continue its upward trajectory, with potential resistance at $41.00 and $44.00.

Defined Risk Strategy Recommendations:

Based on the price forecast, consider the following defined risk strategies:

1. Bull Call Spread: Buy TEVA 261009C00039000 (1.48) and sell TEVA 261009C00041000 (0.55), with a net debit of 0.93, max profit of 1.07, and breakeven at 39.93.
2. Iron Condor: Sell TEVA 261009C00040000 (1.04) and buy TEVA 261009P00038000 (0.82), while selling TEVA 261009P00036000 (0.38) and buying TEVA 261009C00042000 (0.45), with a net credit of 1.23.
3. Protective Put: Buy TEVA 261009P00039000 (1.2) to protect a long position, providing downside protection at a cost of 1.2.

Risk Factors:

• Technical warning signs: Overbought RSI and proximity to Bollinger Bands could indicate a pullback.
• Sentiment divergences: A sudden shift in sentiment could impact the stock price.
• Volatility and ATR: Increased volatility could affect the strategy outcomes.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA shows bullish momentum with strong institutional buying and technical indicators supporting continuation higher.